Berkshire Grey (US:BGRY), the e-commerce sector-focused robotics and AI company, is set to rise on Monday following news of a takeover deal from Japan-listed Softbank Group (JP:9984) that was announced after the close of trading for the week. BGRY shares rallied 18.4% to $1.35 per share in Friday’s extended trading session. SoftBank Group announced that it...
On March 24, 2023, Argus Research upgraded their outlook for Cracker Barrel Old Country Store (NASDAQ:CBRL) from Hold to Buy. Analyst Price Forecast Suggests 3.27% Downside As of March 24, 2023, the average one-year price target for Cracker Barrel Old Country Store is $108.88. The forecasts range from a low of $92.92 to a high...
On March 24, 2023, Rosenblatt initiated coverage of RingCentral with a Buy recommendation. Analyst Price Forecast Suggests 95.65% Upside As of March 24, 2023, the average one-year price target for RingCentral is $52.55. The forecasts range from a low of $38.38 to a high of $68.25. The average price target represents an increase of 95.65%...
On March 22, 2023, Barclays upgraded their outlook for Nike (NYSE:NKE) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 10.48% Upside As of March 23, 2023, the average one-year price target for Nike is $132.03. The forecasts range from a low of $85.85 to a high of $194.25. The average price target represents an increase...
On March 21, 2023, Bernstein initiated coverage of Beam Therapeutics with a Market Perform recommendation. Analyst Price Forecast Suggests 126.65% Upside As of March 21, 2023, the average one-year price target for Beam Therapeutics is $73.05. The forecasts range from a low of $45.45 to a high of $110.25. The average price target represents an...
On March 17, 2023, Morgan Stanley upgraded their outlook for NVIDIA (NASDAQ:NVDA) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 1.45% Downside As of March 17, 2023, the average one-year price target for NVIDIA is $253.41. The forecasts range from a low of $111.10 to a high of $336.00. The average price target represents a...
On March 17, 2023, SVB Leerink initiated coverage of Centessa Pharmaceuticals with a Outperform recommendation. Analyst Price Forecast Suggests 46.63% Upside As of March 17, 2023, the average one-year price target for Centessa Pharmaceuticals is $5.86. The forecasts range from a low of $4.04 to a high of $11.55. The average price target represents an...
On March 17, 2023, JP Morgan upgraded their outlook for Chubb (NYSE:CB) from Neutral to Overweight. Analyst Price Forecast Suggests 31.05% Upside As of March 18, 2023, the average one-year price target for Chubb is $251.43. The forecasts range from a low of $207.05 to a high of $283.50. The average price target represents an...
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing ownership of 3.36MM shares of Aclaris Therapeutics Inc (ACRS). This represents 5.0% of the company. In their previous filing dated February 14, 2023 they reported 3.28MM shares and 4.90% of the company, an increase in shares of 2.58%...
On March 15, 2023, Citigroup upgraded their outlook for Unum Group (NYSE:UNM) from Neutral to Buy. Analyst Price Forecast Suggests 22.07% Upside As of March 14, 2023, the average one-year price target for Unum Group is $48.65. The forecasts range from a low of $42.42 to a high of $54.60. The average price target represents...